| Selective cytotoxicity of the NAMPT inhibitor FK866 toward gastric cancer cells with markers of the epithelial-mesenchymal transition, due to loss of NAPRT J Lee, H Kim, JE Lee, SJ Shin, S Oh, G Kwon, H Kim, YY Choi, MA White, ... Gastroenterology 155 (3), 799-814. e13, 2018 | 101 | 2018 |
| Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities S Oh, J Yeom, HJ Cho, JH Kim, SJ Yoon, H Kim, JK Sa, S Ju, H Lee, ... Nature communications 11 (1), 3288, 2020 | 59 | 2020 |
| Pharmacogenomic Analysis Reveals CCNA2 as a Predictive Biomarker of Sensitivity to Polo-Like Kinase I Inhibitor in Gastric Cancer Y Lee, CE Lee, S Oh, H Kim, J Lee, SB Kim, HS Kim Cancers 12 (6), 1418, 2020 | 22 | 2020 |
| Multi-layered proteogenomic analysis unravels cancer metastasis directed by MMP-2 and focal adhesion kinase signaling Y Kwon, SJ Park, BT Nguyen, MJ Kim, S Oh, H Lee, N Park, HS Kim, ... Scientific Reports 11 (1), 17130, 2021 | 14 | 2021 |
| Emerging power of proteomics for delineation of intrinsic tumor subtypes and resistance mechanisms to anti-cancer therapies S Oh, HS Kim Expert Review of Proteomics 13 (10), 929-939, 2016 | 2 | 2016 |
